$109 Million is the total value of BML Capital Management, LLC's 26 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 50.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SGOV | Buy | ISHARES TR0-3 mnth treasry | $27,180,900 | +50.1% | 270,000 | +50.0% | 24.96% | +53.2% |
| AVIR | Buy | ATEA PHARMACEUTICALS INC | $14,400,000 | +72.2% | 4,800,000 | +114.6% | 13.22% | +75.8% |
| CYT | Buy | CYTEIR THERAPEUTICS INC | $9,230,023 | +9.2% | 3,250,008 | +0.0% | 8.48% | +11.5% |
| AVRO | Buy | AVROBIO INC | $6,162,506 | +2430.9% | 4,001,627 | +1461.4% | 5.66% | +2484.0% |
| Buy | ELIEM THERAPEUTICS INC | $5,097,632 | +15.0% | 1,938,263 | +22.4% | 4.68% | +17.4% | |
| FBRX | Buy | FORTE BIOSCIENCES INC | $1,166,247 | -35.4% | 1,761,702 | +1.5% | 1.07% | -34.0% |
| New | VISTAGEN THERAPEUTICS INC | $524,000 | – | 100,000 | +100.0% | 0.48% | – | |
| QQQ | New | INVESCO QQQ TRput | $443,880 | – | 108 | +100.0% | 0.41% | – |
| New | NEOLEUKIN THERAPEUTICS INC | $389,723 | – | 98,664 | +100.0% | 0.36% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-10-23
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR SER TR | 4 | Q3 2023 | 16.9% |
| ADVERUM BIOTECHNOLOGIES INC | 4 | Q3 2023 | 7.4% |
| ELIEM THERAPEUTICS INC | 4 | Q3 2023 | 6.4% |
| ATHIRA PHARMA INC | 4 | Q3 2023 | 4.9% |
| ASTROTECH CORP | 4 | Q3 2023 | 2.8% |
| ARCA BIOPHARMA INC | 4 | Q3 2023 | 1.9% |
| FORTE BIOSCIENCES INC | 4 | Q3 2023 | 1.6% |
| VERRICA PHARMACEUTICALS INC | 4 | Q3 2023 | 2.9% |
| PASSAGE BIO INC | 4 | Q3 2023 | 1.7% |
| RETRACTABLE TECHNOLOGIES INC | 4 | Q3 2023 | 1.0% |
View BML Capital Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-04-24 |
| 13F-HR | 2024-04-23 |
| 13F-HR/A | 2024-02-02 |
| 13F-HR | 2024-01-30 |
| 13F-HR | 2023-10-23 |
| 13F-HR | 2023-07-24 |
| 13F-HR | 2023-04-14 |
| 13F-HR | 2023-02-13 |
View BML Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.